{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:47:32Z","timestamp":1761742052660},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,24]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The aim of the study was to assess the role of the complement system in Staphylococcus aureus arthritis and septicaemia. The murine model of haematogenously acquired septic arthritis was used, injecting intravenously toxic shock syndrome toxin-1 (TSST-1), producing S.\u2003aureus LS-1. Complement was depleted using cobra venom factor (CVF). Evaluation of arthritis was performed clinically and histopathologically. In addition, the effect of complement depletion on the phagocytic activity of leucocytes was assessed in vivo and in vitro. Six days after inoculation of S.\u2003aureus the prevalence of arthritis in decomplemented mice was three-fold higher than that in controls (91% versus 25%). The clinical severity of arthritis at the end of the experiment, expressed as arthritic index, was 7.3 and 1.9, respectively. These findings were confirmed by histological index of synovitis as well as of cartilage and\/or bone destruction being significantly higher in decomplemented mice than in controls (9.8\u2003\u00b1\u20031.7 versus 4.9\u2003\u00b1\u20031.2, P\u2003&amp;lt;\u20030.05; and 7.9\u2003\u00b1\u20031.7 versus 3.0\u2003\u00b1\u20030.9, P\u2003&amp;lt;\u20030.05, respectively). Also, the septicaemia-induced mortality was clearly higher in decomplemented mice compared with the controls. CVF treatment significantly reduced in vivo polymorphonuclear cell-dependent inflammation induced by subcutaneous injection of olive oil and mirroring the capacity of polymorphonuclear cells (PMNC) to migrate and\/or extravasate. Besides, the decomplementation procedure significantly impaired phagocytic activity of peripheral blood leucocytes in vitro, since the number of phagocytes being able to ingest bacteria decreased by 50% when the cells were maintained in decomplemented serum compared with those in intact serum. The conclusion is that complement depletion aggravates the clinical course of S.\u2003aureus arthritis and septicaemia, possibly by a combination of decreased migration\/extravasation of PMNC and an impairment of phagocytosis.<\/jats:p>","DOI":"10.1046\/j.1365-2249.1999.00771.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:13:40Z","timestamp":1047377620000},"page":"95-102","source":"Crossref","is-referenced-by-count":34,"title":["Complement depletion aggravates<i>Staphylococcus aureus<\/i>septicaemia and septic arthritis"],"prefix":"10.1093","volume":"115","author":[{"given":"E","family":"SAKINIENE","sequence":"first","affiliation":[{"name":"Department of Rheumatology, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"BREMELL","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"TARKOWSKI","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"b1_444","unstructured":"1 DL Goldenberg . Bacterial arthritis. In: Kelly WO, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: W.B. Saunders Cooy, 1989 :1567, 85 ."},{"key":"b2_445","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1128\/IAI.59.8.2615-2623.1991","volume":"59","author":"Bremell T","year":"1991","journal-title":"Infect Immun."},{"key":"b3_446","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-3083.1994.tb03392.x","volume":"39","author":"Abdelnour A","year":"1994","journal-title":"Scand J Immunol."},{"key":"b4_447","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/IAI.62.6.2334-2344.1994","volume":"62","author":"Bremell T","year":"1994","journal-title":"Infect Immun."},{"key":"b5_448","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/eji.1830240523","volume":"24","author":"Abdelnour A","year":"1994","journal-title":"Eur J Immunol"},{"key":"b6_449","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/170.1.94","volume":"170","author":"Abdelnour A","year":"1994","journal-title":"J Infect Dis"},{"key":"b7_450","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/art.1780390613","volume":"39","author":"Zhao Y-X","year":"1996","journal-title":"Arthritis Rheum"},{"key":"b8_451","doi-asserted-by":"publisher","DOI":"10.1038\/306378a0"},{"key":"b9_452","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.4049\/jimmunol.155.4.2067","volume":"155","author":"Zhao Y-X","year":"1995","journal-title":"J Immunol"},{"key":"b10_453","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1128\/IAI.62.10.4637-4640.1994","volume":"62","author":"Bremell T","year":"1994","journal-title":"Infect Immun"},{"key":"b11_454","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/IAI.65.7.2517-2521.1997","volume":"65","author":"Verdrengh M","year":"1997","journal-title":"Infect Immun"},{"key":"b12_455","unstructured":"12 IM Goldstein . Complement. Biologically active products. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation. Basic principles and clinical correlates. New York: Raven Press, 1992 :63, 80 ."},{"key":"b13_456","first-page":"335","volume":"2","author":"Frank MM","year":"1988","journal-title":"Baillieres's Clin Immunol Allergy"},{"key":"b14_457","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1172\/JCI106531","volume":"50","author":"Ward PA","year":"1971","journal-title":"J Clin Invest"},{"key":"b15_458","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780230102","volume":"23","author":"Theofilopoulos AN","year":"1980","journal-title":"Arthritis Rheum"},{"key":"b16_459","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00302153","volume":"12","author":"Tarkowski A","year":"1992","journal-title":"Rheumatol Int"},{"key":"b17_460","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1128\/IAI.63.9.3697-3701.1995","volume":"63","author":"Gaede KI","year":"1995","journal-title":"Infect Immun"},{"key":"b18_461","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.1780331120","volume":"33","author":"Bremell T","year":"1990","journal-title":"Arthritis Rheum"},{"key":"b19_462","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/IAI.61.9.3879-3885.1993","volume":"61","author":"Abdelnour A","year":"1993","journal-title":"Infect Immun"},{"key":"b20_463","unstructured":"20 CW Vogel . Cobra venom factor: the complement-activating protein of cobra venom. In: Tu AT, ed. Reptile venoms and toxins, handbook of natural toxins. New York: Marcel Dekker Inc., 1991 :147, 88 ."},{"key":"b21_464","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-71562-4_14","volume":"132","author":"Lansdorp PM","year":"1986","journal-title":"Curr Top Microbiol Immunol"},{"key":"b22_465","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/eji.1830171004","volume":"17","author":"Aarden LA","year":"1987","journal-title":"Eur J Immunol"},{"key":"b23_466","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/eji.1830181010","volume":"18","author":"Helle M","year":"1988","journal-title":"Eur J Immunol"},{"key":"b24_467","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.4049\/jimmunol.139.12.4116","volume":"139","author":"Brakenhoff JPJ","year":"1987","journal-title":"J Immunol"},{"key":"b25_468","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/IAI.60.7.2976-2985.1992","volume":"60","author":"Bremell T","year":"1992","journal-title":"Infect Immun"},{"key":"b26_469","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(65)90004-0"},{"key":"b27_470","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.140.11.3793","volume":"140","author":"Lue C","year":"1988","journal-title":"J Immunol"},{"key":"b28_471","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(86)90347-9"},{"key":"b29_472","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1995.1005"},{"key":"b30_473","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-197805000-00004","volume":"57","author":"Goldenberg DL","year":"1978","journal-title":"Medicine"},{"key":"b31_474","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0008-8749(92)90269-U","volume":"142","author":"Josefsson E","year":"1992","journal-title":"Cell Immunol"},{"key":"b32_475","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916939309077373","volume":"14","author":"Josefsson E","year":"1993","journal-title":"Autoimmunity"},{"key":"b33_476","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1007\/BF01540901","volume":"15","author":"Frank MM","year":"1995","journal-title":"J Clin Immunol"},{"key":"b34_477","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.4049\/jimmunol.151.9.4821","volume":"151","author":"Ferrante A","year":"1993","journal-title":"J Immunol"},{"key":"b35_478","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000236497","volume":"101","author":"Tanoue M","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"b36_479","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0882-4010(86)90028-8","volume":"1","author":"Tuomanen E","year":"1986","journal-title":"Microb Pathogen"},{"key":"b37_480","unstructured":"37 B Heyman . The role of complement receptors in the regulation of the immune response. In: Erdei A, ed. New aspects of complement structure and function. Austin, Texas: R. G. Landes Co., 1994 ."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.1999.00771.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.1999.00771.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/115\/1\/95\/42207291\/j.1365-2249.1999.00771.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/115\/1\/95\/42207291\/j.1365-2249.1999.00771.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:20:12Z","timestamp":1682122812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/115\/1\/95\/6480166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,12,24]]},"published-print":{"date-parts":[[2001,12,24]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00771.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,1]]},"published":{"date-parts":[[1999,1]]}}}